关于我们 / About Us

　　北京旭泽医药科技有限公司前身为北京燕峰晨医药科技发展有限公司，总部设于北京，自2004年正式成立，主营业务为药品研发及注册申报服务，采取委托加工合作方式，取得药品批件进行全国性市场销售。我公司同时寻觅志同道合、优势互补的合作伙伴共谋发展。

    旭泽坚持“质量与高效并重”原则，选择拥有广阔市场前景、有一定核心技术和注册难度的药品进行立项研发，因此具备较强的抗风险能力。我公司专注于药政法规、药品注册咨询服务，包括国内及国际注册代理咨询服务。目前国内已申报原料5个、制剂9个，在研品种8个。另代理国际注册品种24个，其中进口原料药5个，进口辅料注册2个，进口制剂17个。我公司在密切跟踪国内外药政法规动态与技术发展的基础上，竭诚为客户提供专业的服务。

    根据公司战略目标，将通过生产经营与资本运营并举，采用收购兼并、参股控股等形式，有计划、有步骤、积极稳妥地实现公司的可持续发展。

    Xuze Pharmaceutical Technology Co., Ltd. formerly known as Yanfengchen Pharma, is headquartered in Beijing and was formally established in 2004. Its main business is drug research and registration application services. It takes the entrusted processing cooperation to obtain drug approvals and sales in the national market.  At the same time, our company looks for like-minded and complementary partners to seek common development.

    Xuze adheres to the principle of “quality and efficiency”, and selects drugs with broad market prospects, certain core technologies, and registration difficulties to carry out research and development projects, therefore has strong resistance to risks. Our company focuses on drug and regulatory compliance, drug registration consulting services, including domestic and international registered agent consulting services. At present, there are 5 declared raw materials and 9 preparations in China, and 8 varieties are researching. Another agent is 24 international registered products, including 5 imported raw material medicines, 2 registered importing materials, and 17 imported preparations. Our company is dedicated to providing professional services to our customers on the basis of closely tracking the dynamics of domestic and international drug laws and regulations and technological development.

    Xuze has cooperated with Suzhou Tianma Pharma Ltd., Jiangxi Pharma Ltd., Nanchang Hongyi Pharma Ltd and Shanghai Pharmaceutical Group for many years to provide technical support, regulatory and policy training. It has long-term and in-depth project cooperation with Sihuan Pharma group as well as its subsidiaries.

     According to the company's strategic objectives, it will adopt the form of mergers and acquisitions, equity participation, and other forms through production and operation and capital operations. It will implement plans and steps and actively and steadily realize the company's sustainable development.

    Guohua Zhu, President and Founder of Xuze, graduated from Capital Medical University in 1993, worked at the Cancer Hospital of the Chinese Academy of Medical Sciences after graduation, worked as a salesman at Johnson & Johnson Medical Devices Co., Ltd. In 1997, and founded Beijing Yanfengchen Pharma in 2004. Chairman of the company; On March 30, 2012, Xuze Pharmaceutical Technology Co., Ltd.was established and served as the chairman of the company.